NASDAQ: ALLR - Allarity Therapeutics, Inc.

Lønnsomhet i seks måneder: -83.39%
Sektor: Healthcare

Kampanjeplan Allarity Therapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology.

flere detaljer
Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA (ixabepilone), a selective microtubule inhibitor for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. The company was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2021-12-21
ISIN US0167441049
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.allarity.com
Цена ао 0.309
Prisendring per dag: 0% (1.08)
Prisendring per uke: +9.08% (0.9901)
Prisendring per måned: -2.7% (1.11)
Prisendring over 3 måneder: -50.91% (2.2)
Prisendring over seks måneder: -83.39% (6.504)
Prisendring per år: +96.01% (0.551)
Prisendring over 3 år: 0% (1.08)
Prisendring over 5 år: 0% (1.08)
Prisendring over 10 år: 0% (1.08)
Prisendring siden begynnelsen av året: -1.82% (1.1)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV -11.88 0
P/E 0 0
EV/EBITDA -1.89 0
Total: 2.5

Effektivitet

Navn Betydning Karakter
ROA, % -100.33 0
ROE, % 432.61 10
Total: 3.33

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0727 10
Total: 8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 19.63 3
Lønnsomhet EPS, % -99.99 0
Total: 1.4
Flere detaljer

Institusjoner Volum Dele, %
Sabby Management, LLC 359400 7.45
Armistice Capital, LLC 261000 5.41
Citadel Advisors Llc 26215 0.54
Virtu Financial LLC 25795 0.53
TWO SIGMA SECURITIES, LLC 12587 0.26
Tower Research Capital LLC (TRC) 5591 0.12
Wells Fargo & Company 6 0



Veileder Stillingstittel Betaling Fødselsår
Mr. Thomas H. Jensen Founder, CEO & Director N/A 1978 (47 år)
Mr. Peter Buhl Jensen Adj Professor, M.D., M.D., Ph.D., Ph.D. Co-Founder 546.08k 1955 (70 år)
Dr. Steen Meier Knudsen Ph.D. Founder & Chief Scientific Officer 185.11k 1961 (64 år)
Mr. Alexander Epshinsky Chief Financial Officer 1983 (42 år)

Adresse: United States, Boston. MA, 24 School Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.allarity.com